SCHEMBL7656002

SCHEMBL7656002

CCOC(=O)N=C(N)c1ccc(NC(=O)c2ccccc2-c2ccccc2C(=O)NOCc2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.45
NPC1 O15118 8/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
GAA P10253 5/20 0.45
ALDH1A1 P00352 3/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
KDM4E B2RXH2 1/20 0.40
SGMS2 Q8NHU3 1/20 0.40
PLAU P00749 1/20 0.40
PLAT P00750 1/20 0.40
F2 P00734 1/20 0.40
F10 P00742 1/20 0.40
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
F7 P08709 1/20 0.40
F3 P13726 1/20 0.40
PRSS3 P35030 1/20 0.40
LMNA P02545 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663254 0.90 ALDH1A1 (0.47) RAB9ANPC1SMN1; SMN2GAAALDH1A1
SCHEMBL7661471 0.88 CYP3A4 (0.53) RAB9ANPC1SMN1; SMN2GAAALDH1A1
SCHEMBL7654193 0.86 SMN1; SMN2 (0.50) RAB9ANPC1SMN1; SMN2GAAALDH1A1
SCHEMBL7658461 0.86 SMN1; SMN2 (0.56) RAB9ANPC1SMN1; SMN2GAAALDH1A1
SCHEMBL7657150 0.84 CYP3A4 (0.49) RAB9ANPC1SMN1; SMN2GAAALDH1A1
SCHEMBL7659372 0.80 PLAU (0.61) RAB9ANPC1GAASGMS2PLAU
SCHEMBL7662346 0.79 SMN1; SMN2 (0.50) RAB9ANPC1SMN1; SMN2GAAALDH1A1
SCHEMBL7656226 0.77 F2 (0.55) RAB9ANPC1PLAUPLATF2
SCHEMBL7659362 0.76 CYP2C9 (0.51) GAAALDH1A1KMT2AMEN1PLAU
SCHEMBL7688990 0.76 F3 (0.63) F2F10PRSS1PRSS2F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed